Roche Holding AG Stock Swiss Exchange
Stocks
ROG
CH0012032048
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 334.90 CHF | -1.35% |
|
+2.01% | +2.04% |
| Jul. 15 | Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns | MT |
| Jul. 15 | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
| Market Cap | 266B 330B 289B 246B 463B 31,822B 473B 3,185B 1,253B 15,585B 1,241B 1,214B 53,652B | P/E 2026 * |
17.9x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 277B 344B 300B 255B 481B 33,083B 492B 3,311B 1,302B 16,203B 1,290B 1,262B 55,777B | EV / Sales 2026 * |
4.43x | EV / Sales 2027 * | 4.14x |
| Free-Float |
88.78% | Yield 2026 * |
3% | Yield 2027 * | 3.07% |
Last Transcript: Roche Holding AG
| 1 day | -1.35% | ||
| Current month | +3.91% | ||
| 6 months | -1.33% | ||
| Current year | +2.04% |
| Current year | 315.6 | 374.9 | |
| 1 year | 243.9 | 374.9 | |
| 3 years | 212.9 | 374.9 | |
| 5 years | 212.9 | 404.2 | |
| 10 years | 206.35 | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.35% | +2.01% | - | - | 330B | ||
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | ||
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | ||
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | ||
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | ||
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | ||
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | ||
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | ||
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | ||
| -0.36% | +3.64% | +1.91% | -30.15% | 143B | ||
| Average | -0.14% | +1.02% | +25.01% | +49.74% | 376.38B | |
| Weighted average by Cap. | +0.09% | +0.25% | +36.99% | +82.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.6B 77.63B 67.84B 57.7B 109B 7,476B 111B 748B 294B 3,661B 292B 285B 12,604B | 65.29B 80.96B 70.75B 60.18B 113B 7,796B 116B 780B 307B 3,818B 304B 297B 13,145B |
| Net income | 15.22B 18.88B 16.5B 14.03B 26.45B 1,818B 27.04B 182B 71.58B 890B 70.9B 69.35B 3,065B | 16.35B 20.27B 17.72B 15.07B 28.4B 1,952B 29.03B 195B 76.85B 956B 76.13B 74.46B 3,291B |
| Net Debt | 10.56B 13.09B 11.44B 9.73B 18.34B 1,261B 18.75B 126B 49.62B 617B 49.16B 48.08B 2,125B | 3.92B 4.86B 4.24B 3.61B 6.8B 468B 6.95B 46.8B 18.41B 229B 18.23B 17.83B 788B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ROP Stock
- ROG Stock
Select your edition
All financial news and data tailored to specific country editions



















